Lymphoma is a cancer of the lymphatic system and includes a broad group of blood cancers affecting lymphocytes. It is classified into Hodgkin lymphoma and non-Hodgkin lymphoma, each with multiple subtypes that vary in aggressiveness and treatment response. Lymphoma can occur at any age and often presents with painless lymph node swelling.

Common symptoms include fever, night sweats, unexplained weight loss, fatigue, and recurrent infections. Medical oncology is central to lymphoma treatment and is often curative, even in advanced stages.

Systemic chemotherapy remains the backbone of lymphoma treatment and is frequently combined with immunotherapy to improve outcomes. Treatment regimens are tailored based on lymphoma subtype, disease stage, and patient factors.

Advances in targeted therapy and immune-based treatments have significantly improved survival rates for many lymphoma patients. Precision diagnostics allow oncologists to select the most effective therapy while minimizing toxicity.

For relapsed or refractory lymphoma, medical oncology focuses on disease control and long-term management strategies. Supportive care addresses treatment side effects, infection risk, and quality of life.

In Dubai and across the UAE, lymphoma care follows evidence-based international protocols, delivered through multidisciplinary oncology teams committed to comprehensive and compassionate cancer care.